SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein
RxNorm concept 2606074, ingredient (in).
- RxCUI
- 2606074
- Term type
- Ingredient (IN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2606074 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- Nuvaxovid 2026-2027 (BN, has tradename)
- SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 0.01 MG/ML (SCDC, ingredient of)
- SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein Injectable Product (SCDG, ingredient of)
- SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein Injectable Suspension (SCDF, ingredient of)
- SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein Prefilled Syringe (SCDF, ingredient of)
- SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 0.01 MG/ML (SCDC, ingredient of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2606074 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2606074 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2606074. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.